Ami Organics Limited (AMIORG) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Ami Organics Limited (AMIORG) has a cash flow conversion efficiency ratio of 0.087x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs558.65 Million ≈ $6.04 Million USD) by net assets (Rs6.45 Billion ≈ $69.77 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Ami Organics Limited - Cash Flow Conversion Efficiency Trend (2014–2025)
This chart illustrates how Ami Organics Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Ami Organics Limited (AMIORG) total liabilities for a breakdown of total debt and financial obligations.
Ami Organics Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Ami Organics Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ramsay Generale De Sante
PA:GDS
|
0.060x |
|
Rio Tinto PLC
LSE:RIO
|
0.112x |
|
Luye Pharma Group Ltd
F:LUP
|
0.021x |
|
United Corporations Limited
TO:UNC
|
-0.001x |
|
Medartis Holding AG
SW:MED
|
0.026x |
|
Changzhou Tronly New Electronic Materials Co Ltd
SHE:300429
|
0.043x |
|
Shanghai Zhongzhou Special Alloy Materials Co. Ltd.
SHE:300963
|
-0.046x |
|
Henan Hengxing Science & Technology Co Ltd
SHE:002132
|
0.017x |
Annual Cash Flow Conversion Efficiency for Ami Organics Limited (2014–2025)
The table below shows the annual cash flow conversion efficiency of Ami Organics Limited from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see AMIORG stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs13.20 Billion ≈ $142.76 Million |
Rs1.18 Billion ≈ $12.80 Million |
0.090x | -51.10% |
| 2024-03-31 | Rs6.83 Billion ≈ $73.84 Million |
Rs1.25 Billion ≈ $13.54 Million |
0.183x | +66.17% |
| 2023-03-31 | Rs5.94 Billion ≈ $64.23 Million |
Rs655.30 Million ≈ $7.09 Million |
0.110x | +765.36% |
| 2022-03-31 | Rs5.22 Billion ≈ $56.48 Million |
Rs-86.60 Million ≈ $-936.56K |
-0.017x | -110.20% |
| 2021-03-31 | Rs1.67 Billion ≈ $18.05 Million |
Rs271.45 Million ≈ $2.94 Million |
0.163x | -32.85% |
| 2020-03-31 | Rs1.12 Billion ≈ $12.09 Million |
Rs270.77 Million ≈ $2.93 Million |
0.242x | +34.18% |
| 2019-03-31 | Rs822.19 Million ≈ $8.89 Million |
Rs148.38 Million ≈ $1.60 Million |
0.180x | +86.49% |
| 2018-03-31 | Rs576.82 Million ≈ $6.24 Million |
Rs55.82 Million ≈ $603.67K |
0.097x | -85.12% |
| 2017-03-31 | Rs389.92 Million ≈ $4.22 Million |
Rs253.64 Million ≈ $2.74 Million |
0.650x | +140.00% |
| 2016-03-31 | Rs274.24 Million ≈ $2.97 Million |
Rs74.33 Million ≈ $803.85K |
0.271x | +174.08% |
| 2015-03-31 | Rs148.31 Million ≈ $1.60 Million |
Rs-54.26 Million ≈ $-586.80K |
-0.366x | -134.05% |
| 2014-03-31 | Rs107.73 Million ≈ $1.17 Million |
Rs-16.84 Million ≈ $-182.12K |
-0.156x | -- |
About Ami Organics Limited
Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson's, antidepressant, and anticoagulant applications, as wel… Read more